Uma Sinha

Insider Reports History

Entity
Individual
Location
C/O Eidos Therapeutics, Inc., 101 Montgomery Street, Suite 2550, San Francisco, CA
Signature
/s/ Todd Girolamo, attorney in fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Uma Sinha:

Stock Role Class Num Shares Value Price $ Report Date Ownership
PROKIDNEY CORP. Director Director stock option (right to buy) 62.6K May 30, 2024 Direct

Insider Reports Filed by Uma Sinha

Symbol Company Period Transactions Value $ Form Type Date Filed Role
PROK PROKIDNEY CORP. May 30, 2024 1 $0 4 Jun 3, 2024 Director
PROK PROKIDNEY CORP. Jun 29, 2023 1 $0 4 Jul 3, 2023 Director
PROK PROKIDNEY CORP. Jul 11, 2022 1 $0 4 Jul 13, 2022 Director
PROK Social Capital Suvretta Holdings Corp. III Sep 24, 2021 0 $0 3 Sep 24, 2021 Director